Advertisement

Federal Guidelines for Prophylactic ICD Therapy in High Risk Populations for Sudden Cardiac Death: Is this a Necessary Course Correction?

  • Sanjeev Saksena
Editor’s Forum

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Medicare Draft Decision Memo for Implantable Defibrillators (CAG-00157R2) Sept. 28, 2004.Google Scholar
  2. 2.
    Axtell K, Tchou P, Akhtar M. Survival in patients with depressed left ventricular function treated by implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1991; 14(2 Pt 2):291–296.Google Scholar
  3. 3.
    Mehta D, Saksena S, Krol RB. Survival of implantable cardioverter-defibrillator recipients: Role of left ventricular function and its relationship to device use. Am Heart J 1992;124:1608–1614.CrossRefGoogle Scholar
  4. 4.
    Domanski MJ, Saksena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E for the AVID investigators: Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 1999;34:1090–1095.CrossRefGoogle Scholar
  5. 5.
    AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576–1583.Google Scholar
  6. 6.
    Bardy GH. SCD-HeFT: The Sudden Cardiac Death in Heart Failure Trial. ACC meeting, 2004. http://www.acc04online.org/ondemand/trials1/sessions.asp?link=R
  7. 7.
    Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002;105:1453–1458.CrossRefGoogle Scholar
  8. 8.
    Bigger JT for the (for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators). Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997;337:1569–1575.CrossRefGoogle Scholar
  9. 9.
    Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, De Vries DW, Feldman AM; Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–2150.CrossRefGoogle Scholar
  10. 10.
    Moss AJ, Hall WJ, Cannom DS, Daubert P, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl Med 1996;335:1933–1940.CrossRefGoogle Scholar
  11. 11.
    Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–883.CrossRefPubMedGoogle Scholar
  12. 12.
    Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F, AMIOVIRT Investigators. Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and Asymptomatic nonsustained ventricular tachycardia—AMIOVIRT. J Am Coll Cardiol 2003;41:1707–1712.CrossRefGoogle Scholar
  13. 13.
    Saksena S. Bundle branch block and cardiac resynchronization therapy: Do we need to look further before we leap? J Intervent Card Electrophysiol 2003;8:163.CrossRefGoogle Scholar
  14. 14.
    Nudell BM. Medical devices: QRS risk stratification & bang for the buck. Sanford C. Bernstein & Co., LLC Research Call, (05/24/2004).Google Scholar
  15. 15.
    Nudell BM. Cost per life year saved for low risk ICD populations; consequences for European adoption. Sanford C. Berstein & Co., LLC Research Call, (09/14/2004).Google Scholar
  16. 16.
    Rudolph F. Evonich, Alok Maheshwari, Joseph C. Gardiner, Atul Khasnis, Sricharan Kantipudi, John H. Ip, Denise Grimes, Gregory Hayter, Ranjan K. Thakur. Implantable cardioverter Defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia. J Intervent Cardiol Electrophysiol 2004;11:59.CrossRefGoogle Scholar
  17. 17.
    Schoenfeld MH for the NASPE Task Force on the Implementation of an Arrhythmia Device/Lead Database: NASPE Policy Statement: Recommendations for implementation of a North American Multicenter Arrhythmia Device/Lead Database. PACE 1992;15:1632-1636.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Sanjeev Saksena

There are no affiliations available

Personalised recommendations